SCHEMBL210209

SCHEMBL210209

CC([C]=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8896312 0.76
SCHEMBL9063449 0.76 TP53 (0.47)
SCHEMBL28823468 0.75
SCHEMBL744169 0.73
SCHEMBL5525436 0.71
SCHEMBL13725798 0.71
SCHEMBL1417959 0.71
SCHEMBL9494396 0.71
SCHEMBL14040005 0.71
SCHEMBL185750 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 659 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11738087-B2 Lymph directing prodrugs MONASH UNIVERSITY (AU) 2023-08-29 US claimed
CN-107580596-B Sulfimidoylpurine ketone compounds and derivatives for the treatment and prevention of viral infections 豪夫迈·罗氏有限公司 2020-07-14 CN claimed
US-20200109144-A1 Sulfonimidoylpurinone Compounds HOFFMANN-LA ROCHE INC. (US) 2020-04-09 US claimed
EP-3294740-A1 NOVEL SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION H. Hoffnabb-La Roche Ag (CH) 2018-03-21 EP claimed
CN-107580596-A For treating and preventing the new sulphur imido acyl group purinone compound and derivative of virus infection 豪夫迈·罗氏有限公司 2018-01-12 CN claimed
US-20170275286-A1 Novel Sulfonimidoylpurinone Compounds and Derivatives for the Treatment and Prophylaxis of Virus Infection HOFFMANN-LA ROCHE INC. (US) 2017-09-28 US claimed
WO-2016180695-A1 NOVEL SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2016-11-17 WO claimed
US-20160326177-A1 Novel Sulfonimidoylpurinone Compounds and Derivatives for the Treatment and Prophylaxis of Virus Infection HOFFMANN-LA ROCHE INC. (US) 2016-11-10 US claimed
CN-102947300-B Alkaloid amino ester derivative and pharmaceutical composition thereof 奇斯药制品公司 2016-09-21 CN claimed
EP-2643000-A2 THERAPEUTIC PIPERAZINES Dart Neuroscience (Cayman) Ltd (KY) 2013-10-02 EP claimed
US-4912090-A Antiparasitic milbemycin and avermectin derivatives SANKYO COMPANY LIMITED (JP) 1990-03-27 US claimed
EP-0346108-A2 Anti-infective nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1989-12-13 EP claimed
EP-0230347-A1 Macrolide compounds, their preparation and use Sankyo Company Limited (JP) 1987-07-29 EP claimed
US-4659734-A BACTERICIDES, FUNGICIDES NIPPON SHINYAKU CO., LTD. (JP) 1987-04-21 US claimed
US-4619943-A NEUROLEPTIC AGENTS RAO KOPPAKA V 1986-10-28 US claimed
EP-0158513-A2 Antiviral compounds THE WELLCOME FOUNDATION LIMITED (GB) 1985-10-16 EP claimed
US-4419522-A ANTITUMOR AGENTS CHINOIN GYOGYSZER VEGYESZETI TERMEKEK GYARA RT. (HU) 1983-12-06 US claimed
EP-0040435-B1 PEPTIDE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Eisai Co., Ltd. (JP) 1983-07-20 EP claimed
EP-0040435-A1 Peptide derivatives and process for the preparation thereof Eisai Co., Ltd. (JP) 1981-11-25 EP claimed
US-4002665-A Process for substituted cyclohexenes and its products WARNER-LAMBERT COMPANY (US) 1977-01-11 US claimed